… Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT)
Research Group. Effect of long-term oral anticoagulant treatment on mortality and …

… MA Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral
anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves. …

… patients with certain types of valvular heart disease (VHD), and … Valvular heart disease is
a broad category of disorders … heart disease subanalyses of direct oral anticoagulant atrial …

… role of oral anticoagulants with and without antiplatelet therapy in patients with established
coronary artery disease (CAD). Randomized trials in which oral anticoagulants were tested in …

… Vitamin K antagonists, also known as oral anticoagulants (OACs), are widely used for the
treatment and prophylaxis of thromboembolic diseases. Short-term OAC treatment is often …

… Treatment with oral anticoagulants is also indicated in patients with valvular heart disease
or dilated cardiomyopathy to prevent systemic arterial embolism, although its effectiveness …

… heart disease, degenerative valve lesions, or following implantation of artificial material [1,2].
It is assumed that oral anticoagulation is … , the intensity of oral anticoagulation therapy was …

… oral anticoagulants, but with numerous limitations that prompted the introduction of new
oral anticoagulants … Overall, the new oral anticoagulants are poised to replace vitamin K …

… (A) Increased use of (novel) oral anticoagulants in adults with congenital heart disease
over … ) and novel oral anticoagulants (NOACs) in adults with congenital heart disease (ACHD) …

… oral anticoagulants or non‐vitamin K antagonist oral anticoagulants or direct oral anticoagulants
… or intracranial hemorrhage AND valvular heart disease or mitral regurgitation or aortic …